OncoSil Medical (ASX:OSL) secured a distribution deal with Al Zahrawi Medical Supplies to distribute its pancreatic cancer therapy, OncoSil, in countries belonging to the Gulf Cooperation Council (GCC) in the Middle East, according to a Monday filing with the Australian bourse.
The deal includes exclusive rights to market and sell the product in GCC member countries such as United Arab Emirates, Qatar, Oman, and Bahrain, the filing said.
The medical device company's shares fell past 7% in recent Monday trade.
Price (AUD): $0.01, Change: $-0.001, Percent Change: -7.14%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.